Brooklyn Park woman first to sue Twin Cities clinic over meningitis

Author:
Updated:
Original:

A 23-year-old Brooklyn Park woman is the first to sue a Twin Cities pain clinic for negligence after she received two steroid injections there last summer and developed meningitis, the Star Tribune reports.

Traci Maccoux filed the suit Monday against Medical Advanced Pain Specialists, the newspaper reported. “I was hoping that they would know better,” she told the newspaper. “You go somewhere and you just assume that things are safe.”

Maccoux was among the 700 people who developed meningitis from steroids contaminated with a fungus at a production facility in Massachusetts. Twelve of those cases were in Minnesota, according to the Centers for Disease Control, which tracks the cases in a state-by-state map.

The contaminated steroids were manufactured and distributed throughout the U.S. by the New England Compounding Center, U.S. health officials have said. Last week, the Centers for Disease Control and Prevention reported that two more people have died from fungal meningitis and secondary infections, the Boston Herald reported.

The total death toll is now 50, FOX News reported.

One of those deaths was in Minnesota, according to the CDC.

Next Up

Adam Thielen

Vikings place Adam Thielen on COVID-19/reserve list

Thielen is coming off a two-touchdown game against the Cowboys.

MCF Oak Park Heights

COVID-positive inmate at Oak Park Heights prison dies

He becomes the fourth prison inmate to die from the virus.

Screen Shot 2020-11-23 at 1.08.19 PM

2-ton smoker stolen from Twin Cities chef Thomas Boemer

Boemer is the chef behind restaurants including the popular Revival.

Governor Tim Walz

Walz says relief package is coming for Minnesota small businesses

Walz is prepared to call a special session and pass the package immediately.

Governor Tim Walz

Watch live: Gov. Tim Walz COVID-19 press conference Monday

Walz will be introducing a new app that helps Minnesotans track COVID-19 exposures.

Related

5th case of meningitis reported in Minnesota

Minnesota health officials announced a fifth case of meningitis linked to tainted steroids Monday, the Pioneer Press reports. The most recent case is a woman in her 20s. The other four were also women.

Feds: Fewer Minn. clinics got drugs tied to meningitis outbreak than reported

The number of Minnesota clinics that received drugs from a Massachusetts pharmacy tied to the recent fungal meningitis outbreak is fewer than initially reported. The number of the clinics has been adjusted downward from 129 to 111.

Mass. pharmacy in meningitis case not licensed to distribute in Minn.

The Massachusetts pharmacy that supplied a back-pain steroid treatment blamed for a deadly nationwide meningitis outbreak isn't licensed to distribute the drug in Minnesota, the Associated Press reports. About 120 people have been sickened by the outbreak nationwide, including three in Minnesota, and 12 have died.

MDH: 11th case of fungal meningitis confirmed

The Minnesota Department of Health reports another case of fungal meningitis linked to a deadly nationwide outbreak. The new case brings the statewide total to 11. Doctors are finding some patients are developing spine infections following treatment for the infection.

Meningitis outbreak grows nationally, steady in Minnesota

Health officials have confirmed three cases of fungal meningitis in Minnesota, while hundreds of other patients who were injected with a recalled steroid are being tested. An executive with one of the clinics that dispensed the steroid says officials are reassuring patients while also arranging tests for those who need them. Nationwide, the death toll in the fungal meningitis outbreak has reached 11, with the number of cases over 100.

Health officials confirm 9 cases of fungal meningitis

The Minnesota Department of Health says two new cases of fungal meningitis linked to a deadly outbreak has been confirmed, bringing the total to nine in the state. The potentially deadly infections are caused by contaminated injectables produced by the New England Compounding Center of Framingham, Mass.